ALK and neoplasm: A study of in vivo transfected A/J mice with anti-ALK-CD28-CD3ζ-IFN-γ CAR has not reported on the persistence of CAR-DCs, but has documented detectable transfected DCs in the tumor tissue 48 h after nanocomplex injection [193].